Medical-Supplies Companies Object To Proposed New Tariffs
U.S. trade representative hearings bring out hundreds of opponents but also some supporters before July 2 deadline
By Katy Stech Ferek | The Wall Street Journal
June 26, 2019 9:08 am ET
The Wall Street Journal featured article spotlights how medical supply companies are among the healthcare sectors being impacted by tariffs. The article looks at both sides of the issue and includes a quote from HIDA President and CEO Matthew Rowan. HIDA testified before the U.S. Trade Representative’s Office about effects of the proposed new tariffs. View the article through links below (WSJ subscription needed).
For further information on tariffs visit HIDA's tariffs issue page:
(WSJ subscription required)
Excerpted from The Wall Street Journal:
Trade officials have left the pharmaceutical industry and other pockets within the health-care sector out of the trade conflict, but dozens of medical supplies—tongue depressors, exam gloves, surgical gowns and the like— used in everyday patient encounters are among the $300 billion in Chinese imports facing 25% tariffs under the Trump administration’s latest proposal.